Association of phosphatase and tensin homolog low and phosphatidylinositol 3-kinase catalytic subunit alpha gene mutations on outcome in human epidermal growth factor receptor 2-positive metastatic breast cancer patients treated with first-line lapatinib plus paclitaxel or paclitaxel alone

Binghe Xu(Chinese Academy of Medical Sciences & Peking Union Medical College), Catherine Ellis(GlaxoSmithKline (United Kingdom))
Breast Cancer Research
July 23, 2014
10.1186/s13058-014-0405-y
Cited by 31

Related Papers

Customizing local and systemic therapies for women with early breast cancer: the St. Gallen International Consensus Guidelines for treatment of early breast cancer 2021
|Annals of Oncology|2021|792
The role of hypoxia-inducible factor-2 in digestive system cancers
|Cell Death and Disease|2015|124
PRR15 deficiency facilitates malignant progression by mediating PI3K/Akt signaling and predicts clinical prognosis in triple-negative rather than non-triple-negative breast cancer
|Cell Death and Disease|2023|11